14-day Premium Trial Subscription Try For FreeTry Free

Is This A Good Time To Invest In PharmaCyte?

02:59am, Friday, 07'th Jan 2022
Is This A Good Time To Invest In PharmaCyte?
Several penny stocks out there have done very well recently but these three biotechs are waiting for positive FDA news to soar higher. The post 3 Penny Stocks Waiting on FDA Approval for Rocket Fuel a

7 Penny Stocks Waiting on The FDA for Rocket Fuel

12:43pm, Thursday, 09'th Sep 2021
News of regulatory approval or progress would really help to move the needle for these seven biotech penny stocks. The post 7 Penny Stocks Waiting on The FDA for Rocket Fuel appeared first on Investor

PMCB Stock: Why It Is Trading Higher Today

11:00am, Thursday, 09'th Sep 2021
The stock price of PharmaCyte Biotech, Inc. (NASDAQ: PMCB) is trading at over 20% pre-market today. This is why it happened.
There's no denying that PMCB stock has lost much of its value over the years. However, recent developments could catalyze a price resurgence.
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte closes $70 million offering and explains how these funds will be used to grow the Company into the future and create shareholder value.

PharmaCyte Biotech: Buy The 'Dump'

02:08am, Saturday, 21'st Aug 2021
PharmaCyte Biotech: Buy The 'Dump'
The shares of PharmaCyte Biotech, Inc. (NASDAQ: PMCB) increased by 189.47% yesterday. These are some details you should know.
PharmaCyte Biotech (PMCB) stock is taking off Wednesday and there are a few things that potential investors need to know about the company. The post PMCB Stock: 14 Things to Know About PharmaCyte Biot
The shares of PharmaCyte Biotech, Inc. (NASDAQ: PMCB) increased by over 20% pre-market. This is why it happened.
Today, two key catalysts are taking PMCB stock higher, as investors seem to like the positioning of biotech PharmaCyte. The post PMCB Stock: 2 Big Reasons PharmaCyte Biotech Is Soaring 70% Today appea
The shares of PharmaCyte Biotech, Inc. (NASDAQ: PMCB) increased by over 94% during intraday trading. This is why it happened.
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $NASDAQ #NASDAQ--PharmaCyte Biotech announces uplist date to NASDAQ and pricing of $15 million public offering.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE